Debt-to-Equity Swap Capital Increase of 25.8 Billion Won Under Rehabilitation Plan
- Debt-to-equity swap conducted via third-party allotment in accordance with the Seoul Rehabilitation Court's approval of rehabilitation plan (2026-05-12)
- Issuance of 51,660,308 shares totaling KRW 25,830,154,000 (entirely debt conversion, no new cash injection)
- Significant dilution for existing shareholders as 51.6 million new shares are to be listed
- Trustee to apply for court approval of the conversion, followed by registration (payment date: 2026-05-19)
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Securities Issuance Result (Voluntary Disclosure) (Third-Party Allotment Paid-In Capital Increase - Conversion of Investment)
- Company: UNION KOREA PHARM (080720)
- Submission: UNION KOREA PHARM CO.,Ltd
- Receipt: 05-19-2026
- Under KRX KOSDAQ Market Division